Pharma News, 2022

The WHO updated its guidelines to recommend molnupiravir, Merck’s antiviral pill, for treating patients newly diagnosed with Covid-19.

Back in summer 2020, Gilead acquired Immunomedics for $21 billion hoping to turn its breast cancer drug Trodelvy into a megablockbuster.

A new Australian DNA test could rewrite the book on disease diagnosis.

The FDA has denied Ocugen’s Emergency Use Authorization (EUA) request for use of its COVID-19 vaccine in children aged two to 18 years.

The FDA granted orphan drug designation to mocravimod for treatment of patients with acute myeloid leukemia who are undergoing allogeneic hematopoietic stem cell transplantation. ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended that the National Health Service (NHS) offer Amgen’s Lumykras (sotorasib) for patients with nonsmall-cell lung ...

Novel technology combines ACUVUE® daily disposable contact lenses with an established antihistamine in FDA- first in its new category. 

CTI BioPharma announced the U.S FDA has granted accelerated approval to Vonjo (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera o...

Neurons in the brain coexist with and rely on many other cell types to function properly. 

Sanofi seems to be in a betting mood and has been picking up card after card in licensing deals to bulk up its early-stage pipeline. 

The FDA has granted Breakthrough Therapy designation to Pfizer’s respiratory syncytial vaccine (RSV) candidate, RSVpreF, for the prevention of RSV-associated lower respiratory tract illness in in...

The FDA has told Karyopharm Therapeutics that before the agency will grant market approval for Xpovio (selinexor) for front-line maintenance of advanced or recurrent endometrial cancer, the company...